An article by our contributor Irene Tarragó

When I decided to work, I was already 24, I was married and I had already been diagnosed with epilepsy (I was diagnosed at 17). So it seems that my husband married me knowing what baggage I had and he didn’t mind. He’s always been my greatest support. So when I decided to work, with the burden of epilepsy, it didn’t occur to me that it could be an inconvenience.

I didn’t even think about it. I prepared some exams to be hired by the administration and joined the Treasury department, in La Coruña, where we lived then. I did my work without problems. A few years later, in order to become a civil servant, I took an official exam, which I passed, and I then got a permanent position at the Social Security. There I had a seizure at work. My colleagues reacted very well. An ambulance was called and they took me to the hospital. When I went back to work, no one harassed me or gave me any unpleasant treatment because of my condition. They offered me positions of more responsibility and I accepted them.

“The way we look at ourselves is very important. If we see ourselves capable, others will see us capable”

Then we moved to Madrid, so I changed jobs and colleagues. I’ve had no problems because of epilepsy in either of the two work locations I’ve been in Madrid.

The way we see ourselves is very important. If we see ourselves as capable, others will see us as capable. It’s true that there are still a lot of ignorant people who don’t know or don’t want to see, but we have to trust ourselves and our capabilities. In 80% of cases of epilepsy, performance in class, at work and in life in general is equal to that of any person.

I’m aware that there are people with epilepsy with real problems in the workplace. My association, the National Association of People with Epilepsy (ANPE), works so that companies, trade unions and public authorities know what epilepsy is and shake off their fear and become involved so that the stigma of this condition disappears.

Leave a Reply

Open chat
1
Contact with us now
Chat with Anna
¡Hola! 👋🏻
Soy Anna, ¿en qué puedo ayudarte?

The user who fills in the information requested in this form declares to be entitled to do so and is solely responsible for the accuracy and completeness of the data and information entered, expressly exonerating MJN NEUROSERVEIS of any liability that may arise for this entity on the occasion of the information provided through this form.

Yes, I accept

L’usuari que complimenta la informació requerida al present formulari declara estar legitimat per això i es fa responsable exclusiu de la veracitat i integritat de les dades i informació que introdueix, exonerant expressament a MJN NEUROSERVEIS de qualsevol responsabilitat que es pugi generar per aquesta entitat amb ocasió de la informació facilitat a través del present formulari.

Si, accepto

El usuario que cumplimenta la información requerida en el presente formulario declara estar legitimado para ello y se hace responsable exclusivo de la veracidad e integridad de los datos e información que introduce, exonerando expresamente a MJN NEUROSERVEIS de cualquier responsabilidad que pudiera generarse para esta entidad con ocasión de la información facilitada a través del presente formulario.

Sí, acepto

Save the date

The next Saturday 21st of November at 4 pm, you will be able to know first hand our product: mjn-SERAS.
mjn-SERAS is a healthcare product that sends a warning signal when the risk of epileptic seizures is high, to the affected person and their trusted contacts.

Sign up now!


    mjn-SERAS is a medical device with CE marking according to the European Directive 93/42/EEC and the Royal Decree RD. 1591/2009.
    Contraindications: Do not use the product if you suffer from an infection in the ear canal or if you suffer from a skin lesion in the vicinity of the product's area of influence.
    Considerations: This medical product works with an APP only on Android phones. The results tested are 96% sensitivity and 94% specificity.
    CPSP20103CAT.

    Save the date

    El próximo sábado 21 de noviembre a las 4 de la tarde, podrás conocer de primera mano nuestro producto: mjn-SERAS.
    mjn-SERAS es un producto sanitario que lanza una señal de aviso cuando el riesgo de crisis de epilepsia es elevado, a la persona afectada y a sus contactos de confianza.

    ¡Inscríbete!

      mjn-SERAS es un producto sanitario con marcado CE conforme a la Directiva Europea 93/42/EEC y el Real Decreto RD. 1591/2009.
      Contraindicaciones: No usar el producto en caso de padecer una infección en el canal auditivo o en caso de padecer una lesión cutánea en las proximidades del área de influencia del producto.
      Consideraciones: Este producto sanitario funciona con una APP solo en teléfonos Android. Los resultados testeados son 96% de sensibilidad y 94% de especificidad.
      CPSP20103CAT.